Quick Order Cart

Cat. No. ARG39332

DNAJC6 Knockout Raji Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Bone

  • Disease:

    Burkitt lymphoma

The DNAJC6 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the Raji B lymphocyte line, featuring disruption of the DNAJC6 gene encoding auxilin, an Hsc70 co-chaperone essential for clathrin-mediated endocytosis. This model enables investigation of endocytic trafficking and receptor internalization in a B cell context. Knockout of auxilin impairs clathrin uncoating, affecting surface levels of transferrin receptor and EGFR, making the cells suitable for transferrin uptake assays, immunofluorescence studies of clathrin dynamics, and co-immunoprecipitation of Hsc70?Cclathrin complexes. Applications include endocytosis research, neurodegenerative disease modeling (PARK19), and drug delivery studies.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    Raji

    Cell Type

    B cell line

    Sex of Donor

    Male

    Age

    11 years

    Derived From Site

    In situ; Maxilla

    Gene Name

    DNAJC6

    Gene Identifier

    NCBI Gene ID 9829

    Morphology

    Lymphoblast-like

    Growth Mode

    Suspension

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC6 Knockout Raji Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population derived from the human Burkitt’s lymphoma B lymphocyte line Raji, in which the DNAJC6 gene has been disrupted to abolish expression of functional auxilin. This polyclonal population retains diverse editing events across cells, providing a heterogeneous loss-of-function model that avoids clonal artifacts and reflects the complexity of gene disruption at the population level.

Raji cells are an Epstein-Barr virus (EBV)-positive, suspension-growing B lymphocyte line established from a Burkitt’s lymphoma. They carry the characteristic t(8;14) translocation that juxtaposes the c-MYC oncogene with the immunoglobulin heavy-chain locus, resulting in constitutive c-MYC overexpression. Widely employed as a model for B cell biology and lymphomagenesis, Raji cells express surface B cell receptors, transferrin receptors, and various signaling receptors, making them a robust platform for investigating endocytic trafficking and membrane dynamics.

The DNAJC6 gene encodes auxilin, a J-domain?Ccontaining co-chaperone that recruits Hsc70 (HSPA8) to clathrin-coated vesicles. Auxilin stimulates Hsc70??s ATPase activity, driving clathrin lattice disassembly after endocytosis. In clathrin-mediated endocytosis, auxilin functions downstream of receptor activation by ligands such as transferrin and EGF, which engage the AP2 adaptor complex and clathrin triskelion at the plasma membrane. Auxilin interacts directly with clathrin heavy chain and Hsc70, and its activity is essential for uncoating of endocytic vesicles carrying transferrin receptor and epidermal growth factor receptor. Dynamin mediates vesicle scission upstream of auxilin, completing the cycle of receptor internalization and clathrin recycling.

Knockout of DNAJC6 in Raji cells is predicted to impair clathrin-mediated endocytosis by blocking vesicle uncoating, leading to accumulation of coated pits, altered surface receptor levels, and reduced internalization of ligands such as transferrin and EGF. This defect likely impacts B cell receptor trafficking and downstream signaling pathways that depend on receptor endocytosis for attenuation or sustained activation. As mutations in DNAJC6 are linked to autosomal recessive juvenile Parkinson disease (PARK19), this knockout model provides a unique intersection between neurodegenerative disease mechanisms and B lymphocyte cell biology, enabling studies of auxilin??s role in endocytic homeostasis.

Researchers can employ the DNAJC6 Knockout Raji Polyclonal Cells as a versatile tool to dissect clathrin-mediated endocytosis and receptor trafficking. Representative applications include transferrin uptake assays to quantify endocytic efficiency, EGF internalization kinetics, immunofluorescence microscopy to visualize clathrin coat accumulation, flow-cytometric measurement of surface transferrin receptor and EGFR levels, and co-immunoprecipitation of Hsc70?Cclathrin complexes. The model also supports investigations into drug delivery mechanisms via endocytosis and can serve as a cellular system to study molecular events underlying Parkinson??s disease?Crelated neurodegeneration. For additional information or to discuss custom gene-editing projects, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)